BBIO
BridgeBio Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$76.42
+3.23%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 23.47x
- P/S forward
- 10.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -8.96x
- Price / sales
- 15.74x
- Price / cash flow
- -40.35x
Enterprise value
- Enterprise value
- $16.8B
- EV / sales
- 17.76x
- EV / EBITDA
- -38.12x
- EV / EBIT
- -40.97x
- Market cap
- $14.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026